Cloud-based analysis platform for in-house DNA sequencing: plasmid validation

Biological manufacturers are now starting to make chemicals and biological products (like proteins) by growing large amounts of microorganisms like bacteria or algae. One major quality control step in the manufacturing process is to check the genetic sequences of these microorganisms because they often not correctly made. This is due to the biological method for […]

Read More
Developing computation tools for the rational design of cyclic peptide therapeutics

The majority of drugs that enter the market are discovered by screening millions of random chemical compounds until a desired effect is achieved. With the recent explosion in available biological data and raw computing power, it is now possible to develop drugs through bottom-up design rather than trial-and-error testing. Bottom-up drug design has the potential […]

Read More
Development of an integrated foundation for precision medicine for the Atlantic Region with a focus on Colorectal Cancer and Lung cancer

Atlantic Canada has the highest rate of CRC in Canada and NL has the highest incidence of familial CRC worldwide. This study is being undertaken primarily to reveal the underlying molecular mechanisms associated with the high rate of CRC in Atlantic Canada, particularly the well-documented familial CRC in NL. We expect to define novel genetic […]

Read More
Methods development and applications for neuromelanin-sensitive MRI

Dopamine and noradrenaline are neurotransmitters that are released from neurons located in the substantia nigra and locus coeruleus. Therefore, these brain structures have the unique property of containing high concentrations of neuromelanin, a dark pigment that can be visualized with specialized MRI sequences. The neuromelanin-sensitive MRI signal has been used to visualize degeneration of these […]

Read More
Further development of protein-based biosensors and assessment of their commercialization potential within the Canadian aquaculture industry

In the agri-food industry, monitoring the production and/or processing of raw materials can be important for ensuring the quality of the end-product. Measurement of specific compounds during processing can provide the feedback required to make informed adjustments resulting in a quality enhancement of the product. Biosensors are the devices that can provide detection and/or quantification […]

Read More
Development and commercialization of epigallocatechin monolaurate as a novel antioxidant alternative in preventing oxidative deterioration of marine omega-3 products

Canada is known globally for its prosperous fishery industry. Meanwhile, omega-3 lipids are extensively manufactured and commercialized as value-added by-products of fishery processing wastes in Canada. However, the marine omega-3 lipids are highly unsaturated and oxidizable. The oxidization of omega-3 lipids leads to significant quality loss of products. The addition of lipidic antioxidants prevent lipid […]

Read More
Rapid metagenomic characterization of surface microbiota in Emergency Medical Services Vehicles

Hospital Acquired Infections (HAI) occur in approximately 7% of hospitalized patients in developed countries producing unnecessary burden to healthcare systems. The frequency of HAI caused by antibiotic resistant pathogens that spread via surfaces, for example methicillin-resistant Staphylococcus aureus (MRSA), is also rising. To address this growing concern, dsBioscience Inc. is partnering with the University of […]

Read More
Prevention of microbial persistence on surfaces for Infection Control

The goal of the internship with Bioshield Technologies Canada, a developer of antimicrobial and biostatic products, is to evaluate a product formulated to be used as a surface treatment for microbial control. The project is part of a comprehensive research program aimed at developing improved protocols for infection and contamination in the hospital and food […]

Read More
Developing highly sensitive biosensors for MRSA bacterial detection

Nosocomial infection is a growing problem in Canadian hospitals, these bacteria can kill as many as 8,000 patients per year, and the expenses reach at least $100 million annually. Clostridium difficile (C. difficile) and methicillinā€resistant Staphylococcus aureus (MRSA) are among the most common bacteria. For example, C. difficile has killed more than 600 people in […]

Read More
Architecture and application of an innovative decision-support module for use in primary care with electronic patient records

This project is designed to develop a decision-support module to be used with electronic patient records. By using innovative methodologies to analyze patient data as well as the sharing of such data with clinicians and the patients themselves, the project seeks to resolve current problems faced by clinical decision-support information systems (including problems that have […]

Read More